RedHill sells Talicia to Apotex for $18M upfront plus milestones

Go back to RedHill sells Talicia to Apotex for $18M upfront plus milestones

RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

August 31, 2026 7:00 AM EDT

Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company's commercial business toward new and larger product opportunities, revenue growth and an accelerated path toward operational profitability

--

Realizes substantial value from RedHill's 70% stake in Talicia, currently held within a shared ownership and economic structure, while immediately creating a stronger liquidity position and fully funding the next major steps in RedHill's transformational commercial expansion

--

Under the terms of the agreement,... More